According to the research report titled ‘Biological Safety Testing Market, By Products and Services (Products {Kits and Reagents, Instruments}, Services), By Test (Endotoxin Test, Sterility Test, Adventitious Agent Detection Test), By Application (Blood & Blood-based Products, Vaccines & Therapeutics, Stem Cells), By End-use (Pharmaceutical and Biotechnology Companies, Contract Development and Manufacturing Companies, Research and Academia), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 - 2025’, available with Market Study Report, global biological safety testing market is expected to reach a valuation of USD 4.5 billion by the year 2025.
 

High investment in clinical research, rising implementation of the testing technology, and soaring focus on drug development research activities are catalyzing global biological safety testing market.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2337490/
 

Additionally, increasing number of biopharmaceutical firms and laboratories, surging risk of HAIs (healthcare associated infections) as well as strict regulatory guidelines and government initiatives for minimizing contamination while optimizing manufacturing process are augmenting the growth of the industry share.
 

Elaborating on the negatives, lack of trained professionals, coupled with high cost of the biological safety testing cabinet are likely to refrain the industry growth over the projected timeframe.
 

Based on products and services ambit, the services segment is anticipated to register 12.4% CAGR through 2025, owing to customized offerings by service providers which focus on meeting specific requirement of biopharmaceutical products, alongside focus among drug manufacturers to reduce cost burden.
 

In terms of test, the endotoxin test segment of worldwide biological safety testing market captured 23% revenue share in 2018, owing to the test’s ability to identify presence of bacterial contamination in biologicals for ensuring product safety for human use, as well as to determine total microbial burden and pyrogen.
 

Speaking of application scope, the blood & blood-based products segment is poised to grow notably over the analysis timeframe, owing to its adoption in surgeries and cosmetic. On the other hand, stem cells segment is to register stellar growth during 2019-2025, creditable to rising burden of diseases such as autoimmune diseases, arthritis and congenital disorders.
 

In terms of end-user terrain, the pharmaceutical and biotechnology companies segment is slated to flourish over the ensuing years, owing to proliferating new entrants providing novel drugs and therapeutics as well as availability of safety testing services from raw materials to final manufacturing.
 

As per expert verbatim, Canada industry accounted for USD 81 million in 2018 and is slated to grow significantly through 2025, owing to escalating funding towards vaccine and pharmaceutical companies, modern manufacturing facilities, advanced healthcare infrastructure, and implementation of avant-garde techniques.
 

Leading companies in global biological safety testing market include Esco Micro Pte Ltd., Promega Corporation, WuXi Biologics, Pharmabiotic Research Institute, The Merck Group, Thermo Fisher Scientific, The Sartorius Group, Eurofins, Toxikon Corporation, SGS S.A., Charles River Laboratories International Inc., and Lonza Group among others.